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Abstract: This report describes a complicated course of a 58-year-old patient with multicentric Barrett’s carcinoma within 
a long-segment of Barrett metaplasia. After abdominal-thoracic resection of the cancer, with incomplete removal of the 
long-segment metaplastic lesion, invasive carcinoma was diagnosed in the remnant Barrett’s segment. Endoscopic mucosal 
resection was done, but Barrett’s mucosa was left in situ again. Recurrent tumor growth was diagnosed only few months 
later. Finally, transthoracic complete resection on the remnant Barrett’s segment was performed. Thus, our case demonstrates 
impressively the appearance of multicentric adenocarcinomas in Barrett’s esophagus and underlines the necessity of resec-
tion of the complete Barrett mucosa.
Introduction
Barrett’s esophagus (BE) is an acquired disease of the esophagus. Normal distal stratiﬁ  ed squamous 
epithelium is transformed into metaplastic intestinal type columnar epithelium. Since the 1970s, there 
has been a remarkable change in the epidemiology of esophageal malignancy (1). The incidence of 
esophageal adenocarcinoma rose approximately sixfold in the United States. It is discussed, that chronic 
gastroesophageal reﬂ  ux disease (GERD) causes acute mucosal injury, cellular proliferation, and 
specialized columnar metaplasia (2). Ingredients of the gastric reﬂ  uxate—acid and pepsin—cause 
mucosal injury. Bile acids, bile lysolecithin and pancreatic trypsin are suspected to have additional 
malignant inﬂ  uence. It is uncertain, how much time it takes for a transformation to Barrett’s esophagus—
and further (3).
Our case report is that of a patient who developed recurrent esophageal adenocarcinoma during one 
year after partial esophagectomy for Barrett carcinoma with incomplete resection of the premalignant 
lesion.
Patient History
In January 2006, a 58-year-old male was admitted to our hospital with intraepithelial low grade neo-
plasia in the remnant Barrett esophagus. The patient’s height was 174 cm, the weight 86 kg. He was a 
non-smoker and non-alcohol-consumer. Previously the patient has been suffering from hypertension. 
Heart and renal function were normal.
In February 2005, a moderate differentiated Barrett’s adenocarcinoma (G2) had been found, 3 cm 
in diameter. No angioinvasion was observed. The carcinoma was initially located in the distal esopha-
gus within a 15 cm long-segment of specialized intestinal metaplasia, reaching 5 cm below the upper 
esophageal sphincter. No thorough endoscopic biopsy study was done prior to the initial operation. 
Therefore no information on other occult areas of dysplastic tissue was available at that time.
An abdomino-thoracic procedure was performed in September 2005. The primary pathohistological 
examination revealed an early carcinoma with no lymph node involvement and complete resection, 
pT1 pN0(0/13) M0 R0. The resection margin was free of tumor or dysplastic areas. For the reconstruc-
tion the entire stomach was pulled up into the chest and the anastomosis was performed in the mid 
esophagus. The entire segment of intestinal metaplasia was not removed at this time.442
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Due to persistent reﬂ  ux symptoms follow-up 
endoscopy was performed in October 2005. 
Biopsies of a slightly elevated area just above the 
anastomosis within the remnant 3 cm Barrett’s 
mucosa showed high-grade intraepithelial neopla-
sia. Only this visible lesion was biopsied, no 4 
quadrant biopsies were performed at this time. 
Endoscopic mucosectomy was done. Pathologi-
cally, this 0.9x0.7x0.5 cm superﬁ  cial tissue showed 
Barrett’s mucosa, and centrally a well-differenci-
ated adenocarcinoma (M1). Due to persistent reﬂ  ux 
symptoms and need for Proton-Pump-Inhibitors 
the patient was referred to our hospital, a tertiary 
referral center for esophageal diseases.
The patient was admitted in January 2006. On 
endoscopy, remaining Barrett’s tissue was found 
with remnant intraepithelial neoplasia in the area 
of the mucosectomy. Four-quadrant biopsies 
showed low-grade and high-grade intraepithelial 
neoplasia in the remaining Barrrett’s mucosa. 
Tumor marker CA 72-4 was elevated (8.8 U/ml). 
X-rays, using radiopaque material, showed a free 
esophageal passage. There were no strictures 
nearby the gastro-esophageal anastomosis.
A re-thoracotomy was performed and the entire 
segment of intestinal metaplasia removed. In order 
to locate the proximal extent of the Barrett’s seg-
ment metal clips were placed endoscopically one 
day prior of the operation. The resected tissue, 
6x6x0.8 cm in size, showed a well differentiated 
tubular adenocarcinoma, which was limited to the 
mucosa (rpT1m pN0 (0/8), R0, G1, diameter 2 mm) 
with adjacent areas of dysplastic tissue. Extended 
Barrett’s mucosa was found in the area of the 
original anastomosis. The clips were verified 
within the specimen.
Since initially the entire stomach was placed in 
the thoracic cavity a gastric tube could be created 
through the thoracotomy approach with a high 
intrathoracic esophago-gastric anastomosis in the 
posterior mediastinal area was set up. The patient 
remained stable further on, and was discharged 
from our hospital on day 16 postoperatively.
Discussion
After initial diagnosis of Barrett’s adenocarcinoma, 
our patient’s esophagus was just partially removed, 
including the malignant lesions. Barrett’s mucosa 
above the resected area remained in situ. This 
procedure generally requires close follow-up, 
especially in a situation like described in this case 
where a premalignant lesion has been left in situ. 
Four-quadrant-biopsy therefore still represents the 
gold standard for surveillance of BE (Sensitivity 
91%) (4).
Since BE is a tissue of high heterogeneity, and 
four-quadrant-biopsies usually are taken in a mean 
distance of 2 cm, the risk of unrecognised malig-
nancies through sampling errors is of notable 
importance (5). Even by using such a systematic 
biopsy protocol dysplasia and early carcinomas are 
often grossly occult and can easily be missed. 
Therefore during esophagectomy, all conspicuous 
metaplastic tissue besides malignancies should be 
removed. This was omitted twice during the ﬁ  rst 
operation as well as with the second procedure 
mucosectomy.
Retrospectively it becomes obvious that in this 
patient there was a multicentric disease before 
the first operation since carcinoma and high-
grade intraepithelial neoplasia was found within 
one month at two different locations within the 
Barrett’s segment. In face of the short amount of 
time till recurrence, it remains on suspicion, if the 
dysplastic areas might have been existent and 
escaped from diagnosis already in February 2005. 
Consequently, the beneﬁ  t of local treatment strat-
egies (e.g. mucosectomy) of malignancies of this 
entity remains highly debatable. A recurrence rate 
of high-grade intraepithelial neoplasia and early 
cancer up to 30% in endoscopically treated patients 
has been reported previously (6).
Other published studies demonstrated multifo-
cality of high-grade intraepithelial neoplasia and/or 
adenocarcinoma.(7,8) So the presented case is not 
new in regards of multicentric carcinoma within 
Barrett’s esophagus, but the diagnosis, manage-
ment and initial operative approach make it unique 
and emphasize the need to remove all premalignant 
tissue in a patient with a long-segment Barrett’s 
esophagus.
For reconstruction after esophagectomy, the 
method of using the unmodiﬁ  ed stomach for tho-
racic anastomosis with remnant inconspicuous 
esophagus is obsolete. Due to the lack of the lower 
esophageal sphincter, there is a high probability of 
continuous gastroesophageal reﬂ  ux and—after a 
latency period—to develop a BE anew. The prefer-
able technique is to create a gastric tube—by a 
transhiatal en-bloc esophagectomy and proximal 
gastrectomy (9). Once a gastric pull-up is used as 
the reconstruction method it is important to create 
a small tube and not to pull up the entire stomach, 443
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since this will lead to substantial decrease of qual-
ity of life for the patient. Other potential recon-
struction methods are colonic interposition or in 
some rare cases jejunal interposition.
Thus, our case underlines impressively the 
necessity of resection of all Barrett’s mucosa and 
creating a gastric tube to be pulled upwards in 
treatment of adenocarcinomas of the esophagus.
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